JNJ – Johnson & Johnson
JNJ — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
0.97
Margin Of Safety %
-10
Put/Call OI Ratio
0.87
EPS Next Q Diff
0.43
EPS Last/This Y
0.41
EPS This/Next Y
1.03
Price
240.4
Target Price
246.7
Analyst Recom
2.1
Performance Q
15.72
Upside
1.1%
Beta
0.34
Ticker: JNJ
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | JNJ | 248.48 | 0.95 | 0.73 | 367317 |
| 2026-03-04 | JNJ | 245.22 | 0.95 | 0.79 | 374792 |
| 2026-03-05 | JNJ | 239.64 | 0.95 | 0.98 | 375840 |
| 2026-03-09 | JNJ | 242.59 | 0.96 | 0.69 | 373802 |
| 2026-03-10 | JNJ | 243.63 | 0.96 | 0.64 | 379460 |
| 2026-03-11 | JNJ | 243 | 0.95 | 0.59 | 382883 |
| 2026-03-12 | JNJ | 242 | 0.96 | 1.00 | 387245 |
| 2026-03-17 | JNJ | 238.35 | 0.98 | 0.64 | 386693 |
| 2026-03-18 | JNJ | 237.24 | 0.99 | 1.06 | 390356 |
| 2026-03-19 | JNJ | 237.63 | 0.98 | 0.84 | 391029 |
| 2026-03-20 | JNJ | 235.45 | 0.98 | 0.83 | 396517 |
| 2026-03-23 | JNJ | 235.37 | 0.85 | 1.20 | 327491 |
| 2026-03-24 | JNJ | 235.26 | 0.85 | 1.57 | 335401 |
| 2026-03-25 | JNJ | 239.97 | 0.87 | 0.48 | 341868 |
| 2026-03-26 | JNJ | 239.29 | 0.86 | 0.93 | 348102 |
| 2026-03-27 | JNJ | 240.45 | 0.87 | 0.86 | 351962 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | JNJ | 248.48 | -3.0 | 5699.8 | 11.53 |
| 2026-03-02 | JNJ | 248.48 | -3.0 | -608.3 | 11.53 |
| 2026-03-03 | JNJ | 246.79 | -3.0 | -838.7 | 11.53 |
| 2026-03-04 | JNJ | 245.30 | -3.0 | -798.9 | 11.53 |
| 2026-03-05 | JNJ | 239.62 | -3.0 | -1343.0 | 11.53 |
| 2026-03-06 | JNJ | 240.41 | -3.0 | -510.9 | 11.53 |
| 2026-03-09 | JNJ | 242.81 | -3.0 | -299.6 | 11.53 |
| 2026-03-10 | JNJ | 243.72 | -3.0 | -468.1 | 11.53 |
| 2026-03-11 | JNJ | 243.00 | -3.0 | -706.1 | 11.53 |
| 2026-03-12 | JNJ | 242.05 | -3.0 | -735.6 | 11.53 |
| 2026-03-13 | JNJ | 241.57 | -3.0 | -675.0 | 11.53 |
| 2026-03-17 | JNJ | 238.11 | -3.0 | -1271.4 | 11.53 |
| 2026-03-18 | JNJ | 237.24 | -3.0 | -729.3 | 11.53 |
| 2026-03-19 | JNJ | 237.63 | -3.0 | -2178.4 | 11.53 |
| 2026-03-20 | JNJ | 235.37 | -3.1 | -2472.7 | 11.54 |
| 2026-03-23 | JNJ | 235.43 | -3.1 | -2214.9 | 11.54 |
| 2026-03-24 | JNJ | 235.27 | -3.1 | -2241.5 | 11.54 |
| 2026-03-25 | JNJ | 239.96 | -3.1 | -1627.2 | 11.54 |
| 2026-03-26 | JNJ | 239.29 | -3.1 | -2312.2 | 11.54 |
| 2026-03-27 | JNJ | 240.40 | -3.1 | -2087.7 | 11.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | JNJ | -11.64 | 0.01 | 0.86 |
| 2026-03-02 | JNJ | -11.64 | 0.59 | 0.86 |
| 2026-03-03 | JNJ | -11.64 | 0.59 | 0.86 |
| 2026-03-04 | JNJ | -11.74 | 0.59 | 0.86 |
| 2026-03-05 | JNJ | -11.74 | 0.59 | 0.86 |
| 2026-03-06 | JNJ | -10.32 | 0.59 | 0.86 |
| 2026-03-09 | JNJ | -10.32 | 0.64 | 0.86 |
| 2026-03-10 | JNJ | -10.32 | 0.64 | 0.86 |
| 2026-03-11 | JNJ | -10.32 | 0.64 | 1.04 |
| 2026-03-12 | JNJ | -10.32 | 0.64 | 1.04 |
| 2026-03-13 | JNJ | -10.32 | 0.64 | 1.04 |
| 2026-03-17 | JNJ | -10.32 | 0.67 | 1.04 |
| 2026-03-18 | JNJ | -10.32 | 0.67 | 1.04 |
| 2026-03-19 | JNJ | -10.32 | 0.67 | 1.04 |
| 2026-03-20 | JNJ | -10.32 | 0.67 | 1.04 |
| 2026-03-23 | JNJ | -10.32 | 0.67 | 1.04 |
| 2026-03-24 | JNJ | -10.32 | 0.67 | 1.04 |
| 2026-03-25 | JNJ | -10.32 | 0.67 | 0.97 |
| 2026-03-26 | JNJ | -10.32 | 0.67 | 0.97 |
| 2026-03-27 | JNJ | -10.32 | 0.67 | 0.97 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.46
Avg. EPS Est. Current Quarter
2.68
Avg. EPS Est. Next Quarter
2.89
Insider Transactions
-10.32
Institutional Transactions
0.67
Beta
0.34
Average Sales Estimate Current Quarter
23603
Average Sales Estimate Next Quarter
25070
Fair Value
216.72
Quality Score
97
Growth Score
79
Sentiment Score
86
Actual DrawDown %
4.5
Max Drawdown 5-Year %
-18.4
Target Price
246.7
P/E
21.77
Forward P/E
19.14
PEG
2.29
P/S
6.15
P/B
7.1
P/Free Cash Flow
29.41
EPS
11.05
Average EPS Est. Cur. Y
11.54
EPS Next Y. (Est.)
12.58
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
28.46
Relative Volume
0.87
Return on Equity vs Sector %
5.5
Return on Equity vs Industry %
-3.8
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
-2087.7
◆
JNJ
Healthcare
$240.45
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
53.3
Range 1M
41.8%
Sup Dist
0.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
7.1%
EPS NY
8.7%
52W%
89.7%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+5.1% upside
Upside
+5.1%
Quality
97
MoS
-10%
Johnson & JohnsonSector: Healthcare
Industry: Drug Manufacturers - General
Employees: 138200
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
JNJ
Latest News
—
Caricamento notizie per JNJ…
stock quote shares JNJ – Johnson & Johnson Stock Price stock today
news today JNJ – Johnson & Johnson stock forecast ,stock prediction 2023 2024 2025
marketwatch JNJ – Johnson & Johnson yahoo finance google finance
stock history JNJ – Johnson & Johnson invest stock market
stock prices JNJ premarket after hours
ticker JNJ fair value insiders trading